Acupuncture for Migraine Prophylaxis
Overview
Hypothesis: Acupuncture obtains an abiding effect on migraine prophylaxis Design: A open-label randomized controlled trial. 249 participants will be included. Three arms: acupuncture in acupoint-meridian, non-acupoint-meridian group, and waiting list.
Full Title of Study: “A Continuous Study on Abiding Effect of Acupuncture for Migraine Treatment”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: None (Open Label)
- Study Primary Completion Date: September 2014
Detailed Description
Aim: to attest the abiding efficacy and safety of acupuncture for migraine prophylaxis Design: A open-label randomized controlled trial will be performed in Chengdu, Hunan and Chongqing province. Two hundred and forty-three participants will be randomly assign to acupoint-meridian group, non-acupoint-meridian group, and wait-and-see group. Each participants will receive 20 sessions of acupuncture in 4 weeks, with a duration of 30 minutes in a session. After all the treatments was accomplished, there will be 5 times follow-ups in the impending every 4 weeks. The primary outcome is frequency of migraine attacks 16 weeks after inclusion. Secondary outcomes include frequency of migraine attacks at the 4th and 24th week, headache severity, MSQ(Migraine Specific Quality of Life Questionnaire MSQ Version2.1), etc.
Interventions
- Other: acupuncture
- apply acupuncture to prevent the migraine attack
Arms, Groups and Cohorts
- Experimental: acupoint-meridian group
- Apply traditional acupuncture to prevent the migraine attack according to TCM theory
- Other: sham-acupoint group
- sham-acupoint will be penetrated for migraine prophylaxis.
- No Intervention: waiting list
- No acupuncture nor other methods will be conducted in this group.
Clinical Trial Outcome Measures
Primary Measures
- frequency of migraine attacks
- Time Frame: 16th week after inclusion
- to assess the frequency of migraine attacks at the 16th week after inclusion
Secondary Measures
- frequency of migraine attacks
- Time Frame: 4th and 24th week after inclusion
- to assess the frequency of migraine attacks at the 4th and 24th week respectively
- headache severity
- Time Frame: 0 day, 4th, 8th, 12th, 16th, 20th, 24th week after inclusion
- to evaluate the change of severity of headache
Participating in This Clinical Trial
Inclusion Criteria
- Age of a subject is between 18 and 65 years old(initially occured beneath the age of 50), male or female; – in accordance with diagnosis of migraine without aura in International Classification of Headache Disorders, ICHD-2, by IHS; – 2 to 8 times attack per month in recent 3 months, with each period beyond 15 days; – with migraine history for over 1 year; – be able and willing to finish the headache diary in baseline ; – informed consent form must be signed by patient or lineal relative; Exclusion Criteria: – Patients who are unconscious, psychotic. – Patients with aggravating tumor and other serious consumptive disease, and who are subject to infection and bleeding. – With serious primary illness or disease of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on. – Pregnant women or women in lactation.
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 65 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Li ying
- Collaborator
- Hunan University of Traditional Chinese Medicine
- Provider of Information About this Clinical Study
- Sponsor-Investigator: Li ying, Chengdu University of Traditional Chinese Medicine – Chengdu University of Traditional Chinese Medicine
- Overall Official(s)
- Fanrong Liang, Professor, Principal Investigator, Chengdu University of Traditional Chinese Medicine
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.